Understanding life

Next Generation Proteomics Solutions

Large Scale Proteomics

Unprecedented depth and reproducibility over thousands of samples measured across large sample cohorts make Biognosys the partner of choice for large-scale studies.

Understanding life

Next Generation Proteomics Solutions

Take your DIA Data to the Next Level

The Most Complete and Versatile Solution for Quantitative Proteomics

Understanding life

Next Generation Proteomics Solutions

Drug Target Deconvolution

Limited Proteolysis coupled with next-generation Mass Spectrometry (LiP-MS) can directly identify protein drug targets and characterize their binding properties.

Understanding life

Next Generation Proteomics Solutions

Deep Proteomics in Depleted Plasma

Our deep plasma/serum profiling workflow enables robust and reproducible discovery and quantification of 1’000+ proteins in large-scale studies.

Home / Biognosys - Next Generation Proteomics

Biognosys - Next Generation Proteomics

Why proteomics?

Proteomics aims at understanding the proteome by enabling the unbiased and large-scale study of proteins. Watch the video to understand why next generation proteomics should be the technology of choice in studies involving multiplexed protein quantification.

Biognosys Services

We provide services for high-content protein quantification from any species in any biological matrix.

Click to learn more about our services.

 

Biognosys Products

For researchers with access to mass spectrometers we offer a variety of tools that empower researchers to bring next-generation proteomics in-house.

Click to learn more about our products.

 

Biognosys Technology

Biognosys is the leading proteomics company offering services and tools for highly multiplexed protein quantification.

Click to learn more about our technology.

 

Biognosys Online Shop

You are welcome to purchase our standardized products for Next-Generation Proteomics in our online shop.

Click to go to the online shop.

 
BIOGNOSYS

NEWS

03 March 2021

Biognosys Announces Development Roadmap for Large-Scale Discovery Proteomics in Plasma

01 March 2021

Proteomics Meets Health Data Analytics

20 January 2021

Biognosys Announces Appointment of Karel Novy as Chief Operating Officer

16 December 2020

Biognosys Announces Facility Expansion to Support Large-Scale Proteomics

15 December 2020

Biognosys in Publications 2020
 Go to news archive.
BIOGNOSYS

EVENTS

1
March ESMO TAT
8
March US HUPO
9
March AD/PD 2021
 Go to conference calendar
×

Let us help you do great proteomics!

Please click here to contact us.